# CG Health Ventures

> CG Health Ventures is a VC fund in Barcelona backing Health Care and Medical. See 6 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Barcelona, Spain
- Total investments: 6
- Last investment: Sep 2024
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/10160413
- Website: http://www.cghealthventures.com/

CG Health Ventures is a venture capital firm that seeks to invest in the health IT, digital health and genomics domain.

## Contacts

5 contacts available for CG Health Ventures. Shizune tracks 1 team members at CG Health Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/cg-health-ventures?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $549k–$6M |
| Series A | $7.7M–$37M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 5 | 83% |
| Medical | 1 | 17% |
| Women's | 1 | 17% |
| mHealth | 1 | 17% |
| Diabetes | 1 | 17% |

15 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 50% |
| Seed | 2 | 33% |
| Convertible Note | 1 | 17% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 3 | 50% |
| Spain | 2 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Carlos Gallardo | Founder & Managing Director | 2 | https://shizune.co/investors/profile/carlos-gallardo |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Cercle | Cercle advances women's healthcare by unlocking access to insights. Cercle’s platform, the Cercle Biomedical Graph™, transforms healthcare data at scale into real-time, high-quality insights that women's healthcare providers use to run more efficient businesses and provide personalized care. | $6M | Seed | Sep 18, 2024 |  |
| Amelia Virtual Care | Psious develops a virtual reality platform designed to bring value to mental health treatment. The company's platform uses hyper-realistic virtual environments to treat anxiety disorders by means of virtual exposure therapy, enabling professionals to improve mental health therapies. | $7.7M | Series A | Jun 28, 2022 |  |
| Amelia Virtual Care | Psious develops a virtual reality platform designed to bring value to mental health treatment. The company's platform uses hyper-realistic virtual environments to treat anxiety disorders by means of virtual exposure therapy, enabling professionals to improve mental health therapies. | $7.4M | Convertible Note | Jun 28, 2022 |  |
| Babyscripts | Babyscripts’ three-tiered approach to virtual maternity care allows providers to deliver risk-specific care to pregnant mothers at any time, in any place. The first tier consists of a digital education layer delivered via a mobile app, with daily gestational-age and practice-specific, customizable content extending through one year postpartum toengage and empower pregnant mothers through trusted resources. The second tier enables virtual management of pregnant patients through the addition of remote monitoring. Depending on the risk, patients are provided with medical devices (like a bluetooth-enabled blood pressure cuff) to monitor for elevated risk, alerting the provider through a unique trigger alert system to enable risk management and intervention. This smart end-to-end management of patients enables the provider to transition care outside of the clinic and address problems of access, allowing them to automate a majority of their patient care while more effectively allocating time and resources to higher-risk patients. The third tier brings the insurer into the equation in a unique collaboration between the care team and payer, solving some of the structural issues of care coordination and access to care, improving outcomes while reducing cost. | $7.7M | Series A | Jul 20, 2017 |  |
| Virta Health | Virta develops treatments to reversing type 2 diabetes without medications or surgery. Among enrolled patients in its clinical trial at one year, 60% achieved diabetes reversal, and 94% of insulin users reduced or eliminated usage altogether. Results extend beyond diabetes reversal to other areas of metabolic and cardiovascular health, withsustained improvements in blood pressure, inflammation, liver function, and BMI. Delivered through Virta’s novel continuous remote care platform, the Virta Treatment provides unparalleled medical and behavioral support and is transforming the lives of people living with type 2 diabetes. Founded in 2014, the company is headquartered in San Francisco, California. | $37M | Series A | Mar 08, 2017 |  |
| Made of Genes | Genomcore is a professional bioinformatics framework with focus on privacy, compliance and collaborative analysis designed for a broad implementation of precision medicine in a clinical context. Made of Genes is a personal genomics service spined-off from Genomcore. | $549K | Seed | Sep 09, 2016 |  |

6 of 6 investments shown.

## Co-investors
- [Asabys Partners](https://shizune.co/investors/profile/asabys-partners) — VC Fund, 2 deals together
- [Criteria Venture Tech](https://shizune.co/investors/profile/caixa-capital) — VC Fund, 2 deals together
- [Centre for the Development of Industrial Technology (CDTI)](https://shizune.co/investors/profile/centre-for-the-development-of-industrial-technology-cdti) — VC Fund, 2 deals together
- [ENDRA](https://shizune.co/investors/profile/endra-a20a) — VC Fund, 2 deals together
- [AAF Management Ltd.](https://shizune.co/investors/profile/aafmanagement) — VC Fund, 1 deal together
- [Allen & Company](https://shizune.co/investors/profile/allen-and-company) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [ENISA](https://shizune.co/investors/profile/enisa-2) — VC Fund
- [Inveready](https://shizune.co/investors/profile/inveready-technology-investment-group) — VC Fund
- [Angels Capital](https://shizune.co/investors/profile/angels-capital) — VC Fund

## Featured in investor lists
- [Health Care Investors in Spain](https://shizune.co/investors/health-care-investors-spain)
- [Health Care VC Funds in Spain](https://shizune.co/investors/health-care-vc-funds-spain)
- [Medical Device Investors in Spain](https://shizune.co/investors/medical-device-investors-spain)
- [Medical Device VC Funds in Spain](https://shizune.co/investors/medical-device-vc-funds-spain)
- [Wellness Investors in Spain](https://shizune.co/investors/wellness-investors-spain)
- [Consumer Investors in Spain](https://shizune.co/investors/consumer-investors-spain)

## FAQ

### What does CG Health Ventures invest in?

CG Health Ventures invests primarily in Health Care, Medical and Women's startups, most often at Series A and Seed stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is CG Health Ventures's check size?

CG Health Ventures typically joins rounds of $549k–$6M at Seed and $7.7M–$37M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds CG Health Ventures participates in.

### How do I contact CG Health Ventures?

Public channels for CG Health Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at CG Health Ventures?

The team at CG Health Ventures includes Carlos Gallardo (Founder & Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co